SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study.

Pagano J, Perez Arevalo A, Nosanova A, Bauer HF, Loth E, Andres S, Becker F, Otto M, Stefanoni A, Verpelli C, Oeckl P, Schön M, Boeckers T

Open source

DOI: 10.1038/s41398-026-03932-8
Published: 2026 Mar 24
Container: Translational psychiatry
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41398-026-03932-8,
  title = {SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study.},
  author = {Pagano J and Perez Arevalo A and Nosanova A and Bauer HF and Loth E and Andres S and Becker F and Otto M and Stefanoni A and Verpelli C and Oeckl P and Schön M and Boeckers T},
  year = {2026},
  journal = {Translational psychiatry},
  doi = {10.1038/s41398-026-03932-8},
  url = {https://doi.org/10.1038/s41398-026-03932-8}
}

RIS

TY  - JOUR
TI  - SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study.
AU  - Pagano J
AU  - Perez Arevalo A
AU  - Nosanova A
AU  - Bauer HF
AU  - Loth E
AU  - Andres S
AU  - Becker F
AU  - Otto M
AU  - Stefanoni A
AU  - Verpelli C
AU  - Oeckl P
AU  - Schön M
AU  - Boeckers T
PY  - 2026
JO  - Translational psychiatry
DO  - 10.1038/s41398-026-03932-8
UR  - https://doi.org/10.1038/s41398-026-03932-8
ER  -

APA

J, P., A, P. A., A, N., HF, B., E, L., S, A., F, B., M, O., A, S., C, V., P, O., M, S., & T, B. (2026). SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study.. Translational psychiatry. https://doi.org/10.1038/s41398-026-03932-8

Source records

pubmed · retrieved 2026-09-26T06:27:52.860Z
europe-pmc · retrieved 2026-09-26T06:27:52.878Z
doaj · retrieved 2026-09-26T06:27:52.855Z